For Immediate Release
August 20, 2012
Corporate Public Relations Specialist
PerkinElmer Releases Newest Version of Flagship Informatics Product: ChemBioOffice® Ultra 13.0 Suite
New informatics product accelerates the discovery process through increased productivity and data sharing
WALTHAM, Mass. – August 20, 2012 – Today PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, introduced the newest version of ChemBioOffice® Informatics Suite. Version 13.0 increases the productivity of scientists with improvements to the industry leading ChemBioDraw® and ChemBio3D® modules while providing secure cloud storage for improved data sharing.
The ChemBioOffice suite helps chemists and biologists to efficiently track their work giving scientists more time to focus on their research, visualize and gain a deeper understanding of their results and correlate biological activity and other properties with chemical structures. The new informatics product provides individual scientists within an organization the tools they need to create publication-ready drawings of compounds, reactions, materials and their properties for use in electronic laboratory notebooks (ELNs) and databases as well as for querying chemical databases.
“A pressing challenge for our customers is to continually introduce new product candidates into the research and development pipeline in order to maintain competitiveness and ensure ongoing revenues,” said Michael Stapleton, general manager of PerkinElmer Informatics. “We are very excited to provide chemists and biologists with the new ChemBioOffice Suite, a premium tool developed to help scientists turn data into actionable information and make decisions with greater confidence, thereby accelerating their discovery process.”
The improved biopolymer toolbar of the ChemBioDraw program, the world’s leading scientific drawing program, enables fast and easy modifications to larger therapeutic agents and molecular structures such as amino acids, peptides, RNA, DNA and nucleotides. In addition, users can now copy and paste any sequence into the program to manipulate part or the entire section of a sequence in the search for modifications to gain a deeper understanding of their results and correlate biological activity with chemical structures.
To assess the shape and properties of small molecules and biochemical compounds, the ChemBio3D program enables synthetic chemists and biologists to generate 3D models. The ChemBio3D program can evaluate data input and provide valuable information such as the degree of fit of compounds into a receptor. In addition, the program acts as a hub for other 3D modeling programs, providing easy and consistent access to other computational and molecular modeling programs.
The addition of a sharable cloud location into the ChemBioOffice makes it easier for scientists to collaborate by securely sharing and importing ChemBioDraw and ChemBio3D structures, reactions and drawings with other scientists around the world.
Download a Free Trial
A free two-week version of ChemBioOffice Ultra 13.0 and ChemBioDraw are available. Click here to download.
PerkinElmer is a leading provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites which enable customers to create, analyze and communicate chemical, biological, and scientific information more effectively. Learn about our informatics solutions at www.perkinelmer.com/informatics.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The company reported revenue of approximately $1.9 billion in 2011, has about 7,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.